Remote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task force

The COVID-19 pandemic forced a rapid pivot to virtual visits and remote endpoint assessment for clinical research. This pivot provides a key opportunity to optimize the use of remote endpoints in cystic fibrosis (CF) clinical research in order to minimize participant burden, engage more diverse participants and obtain more granular data in a “real world” setting. To better understand remote endpoint measurements for CF clinical research, the Cystic Fibrosis Foundation convened the Remote Endpoint Task Force (Supplement 1), a multidisciplinary group of CF researchers with remote endpoint expertise and community members tasked to bett er understand the current and future use of remote endpoints for clinical research.

Source: Journal of Cystic Fibrosis - February 29, 2024 Category: Respiratory Medicine Authors: Jordana E. Hoppe, Jacquelyn Sjoberg, Gina Hong, Katie Poch, Edith T. Zemanick, Stephanie Thee, Claire Edmondson, Dhiren Patel, Meghana Sathe, Drucy Borowitz, Melissa S. Putman, Noah Lechtzin, Kristin A. Riekert, Melissa Basile, Christopher H. Goss, Mary E Tags: Review Source Type: research